News, Short Squeeze, Breakout and More Instantly...
DURHAM, N.C., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, announced today the pricing of its underwritten public offering of 11,765,000 shar...
DURHAM, N.C., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, announced today that it intends to offer and sell, subject to market and other con...
Are These The Top Biotech Stocks To Watch Now? 3 To Consider Biotech stocks are still amongst the top performers on the stock market as we started off 2021. With numerous life-threatening diseases still running amok, there is a grave need for the treatments these companies d...